BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/8/2024 7:49:58 AM | Browse: 242 | Download: 903
 |
Received |
|
2024-04-03 14:52 |
|
Peer-Review Started |
|
2024-04-03 14:52 |
|
First Decision by Editorial Office Director |
|
2024-04-30 09:08 |
|
Return for Revision |
|
2024-04-30 09:08 |
|
Revised |
|
2024-05-13 02:26 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-05-22 13:00 |
|
Second Decision by Editor-in-Chief |
|
2024-05-28 20:20 |
|
Final Decision by Editorial Office Director |
|
2024-05-29 06:14 |
|
Articles in Press |
|
2024-05-29 06:14 |
|
Edit the Manuscript by Language Editor |
|
2024-06-09 01:51 |
|
Typeset the Manuscript |
|
2024-06-21 11:27 |
|
Publish the Manuscript Online |
|
2024-07-08 07:49 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Translational Research |
| Article Title |
Network pharmacology and molecular dynamics study of the effect of the Astragalus-Coptis drug pair on diabetic kidney disease
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Mo-Yan Zhang and Shu-Qin Zheng |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Shu-Qin Zheng, MSc, Associate Professor, Department of Endocrinology, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, No. 33 Beiling Street, Huanggu District, Shenyang 110032, Liaoning Province, China. qxjzsq@sina.com |
| Key Words |
Astragalus membranaceus; Coptis chinensis Franch; Diabetic kidney disease; Network pharmacology; Molecular docking; Molecular dynamics simulation |
| Core Tip |
Network pharmacology, molecular docking, and molecular dynamics simulation studies have demonstrated that diabetic kidney disease (DKD) treatment with the Astragalus-Coptis drug pair involves a diverse range of active ingredients, targets, and pathways. Additionally, quercetin has been found to exhibit strong affinity and binding stability with AKT serine/threonine kinase 1 and tumor necrosis factor, highlighting its potential therapeutic role in DKD. The findings of this study establish a robust theoretical basis for applying the Astragalus-Coptis drug pair in DKD treatment, and these results may provide a guiding framework for further experiments. |
| Publish Date |
2024-07-08 07:49 |
| Citation |
Zhang MY, Zheng SQ. Network pharmacology and molecular dynamics study of the effect of the Astragalus-Coptis drug pair on diabetic kidney disease. World J Diabetes 2024; 15(7): 1562-1588
|
| URL |
https://www.wjgnet.com/1948-9358/full/v15/i7/1562.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v15.i7.1562 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
